Table A3.
HSHH clinical data.
| Clinical Data | Total (n = 47) | Malignancy (n = 30) | Benign (n = 17) |
|---|---|---|---|
| Age, yr (min-max) | 68.0 (35–88) | 70.4 (50–88) | 63.6 (35–87) |
| Sex, male (%) | 28 (63.1) | 18 (60.0) | 10 (58.8) |
| Pathologic diagnosis, n (%) | |||
| NSCLC | 24 (51.1) | 24 (80.0) | 0 |
| Adenocarcinoma | 17 (36.2) | 17 (56.7) | |
| Squamous cell carcinoma | 7 (14.9) | 7 (23.3) | |
| SCLC | 2 (4.3) | 2 (6.7) | 0 |
| Other type of lung malignancy | 3 (6.4) | 3 (10.0) | 0 |
| Malignancy | 1 (2.1) | 1 (3.3) | 0 |
| Negative for malignancy | 17 (36.2) | 0 | 17 (100.0) |
| Methods for pathologic diagnosis | |||
| PCNA | 19 (40.4) | 13 (43.3) | 6 (35.3) |
| Bronchoscopy | 16 (34.0) | 9 (30.0) | 7 (41.2) |
| Transbronchial lung biopsy | 5 (10.6) | 1 (3.3) | 4 (23.5) |
| Surgical operation | 3 (6.4) | 3 (10.0) | 0 |
| EBUS-TBNA | 1 (2.1) | 1 (3.3) | 0 |
| Unknown | 3 (6.4) | 2 (1.1) | 0 |